-
HIV-1 entry inhibitors in the side pocket.
Cell. 1999 Oct 29;99(3):243-6
PMID: 10555140
-
Regulation of human immunodeficiency virus type 1 envelope glycoprotein fusion by a membrane-interactive domain in the gp41 cytoplasmic tail.
J Virol. 2005 Oct;79(19):12231-41
PMID: 16160149
-
AIDS as a zoonosis: scientific and public health implications.
Science. 2000 Jan 28;287(5453):607-14
PMID: 10649986
-
Varying effects of temperature, Ca(2+) and cytochalasin on fusion activity mediated by human immunodeficiency virus type 1 and type 2 glycoproteins.
FEBS Lett. 2000 Jun 2;474(2-3):246-51
PMID: 10838094
-
Evidence for a stable interaction of gp41 with Pr55(Gag) in immature human immunodeficiency virus type 1 particles.
J Virol. 2000 Oct;74(20):9381-7
PMID: 11000206
-
Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion.
J Cell Biol. 2000 Oct 16;151(2):413-23
PMID: 11038187
-
HIV-1 membrane fusion: targets of opportunity.
J Cell Biol. 2000 Oct 16;151(2):F9-14
PMID: 11038194
-
Cooperative subunit interactions within the oligomeric envelope glycoprotein of HIV-1: functional complementation of specific defects in gp120 and gp41.
Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12794-9
PMID: 11050186
-
The highly conserved C-terminal dileucine motif in the cytosolic domain of the human immunodeficiency virus type 1 envelope glycoprotein is critical for its association with the AP-1 clathrin adaptor [correction of adapter].
J Virol. 2001 Mar;75(6):2982-92
PMID: 11222723
-
HIV-1 gp41 six-helix bundle formation occurs rapidly after the engagement of gp120 by CXCR4 in the HIV-1 Env-mediated fusion process.
Biochemistry. 2001 Oct 16;40(41):12231-6
PMID: 11591141
-
Envelope glycoprotein cytoplasmic domains from diverse lentiviruses interact with the prenylated Rab acceptor.
J Virol. 2002 Jan;76(1):327-37
PMID: 11739697
-
Truncation of the cytoplasmic domain induces exposure of conserved regions in the ectodomain of human immunodeficiency virus type 1 envelope protein.
J Virol. 2002 Mar;76(6):2683-91
PMID: 11861835
-
Leucine zipper domain of HIV-1 gp41 interacted specifically with alpha-catenin.
Biochem Biophys Res Commun. 2002 Mar 15;291(5):1239-44
PMID: 11883950
-
Human immunodeficiency virus type 2.
J Gen Virol. 2002 Jun;83(Pt 6):1253-65
PMID: 12029140
-
Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density, and fusion kinetics.
Proc Natl Acad Sci U S A. 2002 Dec 10;99(25):16249-54
PMID: 12444251
-
Identification of gp120 binding sites on CXCR4 by using CD4-independent human immunodeficiency virus type 2 Env proteins.
J Virol. 2003 Jan;77(2):931-42
PMID: 12502809
-
Membrane fusion.
Chem Rev. 2003 Jan;103(1):53-69
PMID: 12517181
-
The HIV Env-mediated fusion reaction.
Biochim Biophys Acta. 2003 Jul 11;1614(1):36-50
PMID: 12873764
-
Regulation of human immunodeficiency virus type 1 Env-mediated membrane fusion by viral protease activity.
J Virol. 2004 Jan;78(2):1026-31
PMID: 14694135
-
Coupling of human immunodeficiency virus type 1 fusion to virion maturation: a novel role of the gp41 cytoplasmic tail.
J Virol. 2004 Apr;78(7):3429-35
PMID: 15016865
-
Impact of mutations in the coreceptor binding site on human immunodeficiency virus type 1 fusion, infection, and entry inhibitor sensitivity.
J Virol. 2004 May;78(10):5476-85
PMID: 15113926
-
The stability of the intact envelope glycoproteins is a major determinant of sensitivity of HIV/SIV to peptidic fusion inhibitors.
J Mol Biol. 2004 Jun 25;340(1):9-14
PMID: 15184018
-
Epitopes of the CD4 antigen and HIV infection.
Science. 1986 Nov 28;234(4780):1120-3
PMID: 2430333
-
Synthesis, oligomerization, and biological activity of the human immunodeficiency virus type 2 envelope glycoprotein expressed by a recombinant vaccinia virus.
Virology. 1990 Sep;178(1):134-42
PMID: 2117828
-
Biological and immunological properties of human immunodeficiency virus type 1 envelope glycoprotein: analysis of proteins with truncations and deletions expressed by recombinant vaccinia viruses.
J Virol. 1991 Jan;65(1):31-41
PMID: 1985202
-
Human immunodeficiency virus type 2 envelope glycoprotein: differential CD4 interactions of soluble gp120 versus the assembled envelope complex.
Virology. 1992 Mar;187(1):233-41
PMID: 1736526
-
Alterations in cell membrane permeability by the lentivirus lytic peptide (LLP-1) of HIV-1 transmembrane protein.
Virology. 1993 Sep;196(1):89-100
PMID: 8356808
-
Effect of amino acid substitutions on calmodulin binding and cytolytic properties of the LLP-1 peptide segment of human immunodeficiency virus type 1 transmembrane protein.
J Virol. 1995 Aug;69(8):5199-202
PMID: 7609094
-
Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions.
J Virol. 1996 Jan;70(1):341-51
PMID: 8523546
-
The CD4-independent tropism of human immunodeficiency virus type 2 involves several regions of the envelope protein and correlates with a reduced activation threshold for envelope-mediated fusion.
J Virol. 1997 Feb;71(2):1453-65
PMID: 8995671
-
A leucine zipper-like sequence from the cytoplasmic tail of the HIV-1 envelope glycoprotein binds and perturbs lipid bilayers.
Biochemistry. 1997 Apr 29;36(17):5157-69
PMID: 9136877
-
Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4.
J Exp Med. 1997 Oct 20;186(8):1383-8
PMID: 9334378
-
A synthetic peptide corresponding to the carboxy terminus of human immunodeficiency virus type 1 transmembrane glycoprotein induces alterations in the ionic permeability of Xenopus laevis oocytes.
AIDS Res Hum Retroviruses. 1997 Nov 20;13(17):1525-32
PMID: 9390752
-
Human erythrocyte glycolipids promote HIV-1 envelope glycoprotein-mediated fusion of CD4+ cells.
Biochem Biophys Res Commun. 1998 Jan 6;242(1):219-25
PMID: 9439639
-
Dilation of the human immunodeficiency virus-1 envelope glycoprotein fusion pore revealed by the inhibitory action of a synthetic peptide from gp41.
J Cell Biol. 1998 Jan 26;140(2):315-23
PMID: 9442107
-
Capture of an early fusion-active conformation of HIV-1 gp41.
Nat Struct Biol. 1998 Apr;5(4):276-9
PMID: 9546217
-
HIV entry and its inhibition.
Cell. 1998 May 29;93(5):681-4
PMID: 9630213
-
Functional dissection of CCR5 coreceptor function through the use of CD4-independent simian immunodeficiency virus strains.
J Virol. 1999 May;73(5):4062-73
PMID: 10196302
-
Structural basis for membrane fusion by enveloped viruses.
Mol Membr Biol. 1999 Jan-Mar;16(1):3-9
PMID: 10332732
-
Stable exposure of the coreceptor-binding site in a CD4-independent HIV-1 envelope protein.
Proc Natl Acad Sci U S A. 1999 May 25;96(11):6359-64
PMID: 10339592
-
The cytoplasmic tail slows the folding of human immunodeficiency virus type 1 Env from a late prebundle configuration into the six-helix bundle.
J Virol. 2005 Jan;79(1):106-15
PMID: 15596806
-
Differential inhibition of HIV-1 and SIV envelope-mediated cell fusion by C34 peptides derived from the C-terminal heptad repeat of gp41 from diverse strains of HIV-1, HIV-2, and SIV.
J Med Chem. 2005 Apr 21;48(8):3036-44
PMID: 15828842
-
Functional interaction between the cytoplasmic leucine-zipper domain of HIV-1 gp41 and p115-RhoGEF.
Curr Biol. 1999 Nov 4;9(21):1271-4
PMID: 10556093